HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott S Zamvil Selected Research

Interferons

1/2020Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?
1/2019The Evolving Mechanisms of Action of Glatiramer Acetate.
8/2011Combining statins with interferon β in multiple sclerosis: think twice, it might not be all right.
11/2002The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott S Zamvil Research Topics

Disease

76Multiple Sclerosis
04/2024 - 09/2002
40Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 09/2002
15Neuromyelitis Optica (Devic's Disease)
01/2023 - 11/2010
15Autoimmune Diseases (Autoimmune Disease)
11/2020 - 11/2002
11Demyelinating Diseases (Demyelinating Disease)
01/2021 - 11/2002
9Paralysis (Palsy)
05/2017 - 11/2002
8COVID-19
11/2023 - 01/2020
8Inflammation (Inflammations)
01/2021 - 04/2006
7Neuroinflammatory Diseases
01/2023 - 06/2003
7Relapsing-Remitting Multiple Sclerosis
01/2019 - 09/2002
5Disease Progression
10/2016 - 09/2002
4Infections
10/2021 - 09/2003
4Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018 - 06/2003
3Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)
07/2024 - 02/2015
3Alzheimer Disease (Alzheimer's Disease)
01/2023 - 06/2003
3Encephalomyelitis (Myeloencephalitis)
01/2023 - 09/2002
3Central Nervous System Diseases (CNS Diseases)
12/2019 - 06/2003
3Neoplasms (Cancer)
01/2018 - 01/2008
3Progressive Multifocal Leukoencephalopathy
08/2010 - 12/2008
2Ganglion Cysts (Ganglion)
01/2023 - 11/2019
2Atrophy
11/2019 - 05/2012
2Chronic Progressive Multiple Sclerosis
01/2016 - 06/2004
2Atherosclerosis
09/2006 - 12/2005
1Paresis (Hemiparesis)
07/2024
1Hypesthesia (Numbness)
01/2024
1Meningeal Tuberculosis (Tuberculous Meningitis)
01/2024
1Acquired Immunodeficiency Syndrome (AIDS)
12/2023
1Breakthrough Infections
11/2023
1Myelitis
01/2023
1Seizures (Absence Seizure)
01/2023
1Transverse Myelitis (Necrotizing Myelitis)
01/2023
1Optic Neuritis (Retrobulbar Neuritis)
01/2023
1Hot Flashes
05/2022
1Thromboinflammation
10/2021
1Thrombosis (Thrombus)
10/2021

Drug/Important Bio-Agent (IBA)

14Glatiramer Acetate (Copaxone)FDA Link
01/2020 - 09/2002
12AntibodiesIBA
01/2023 - 12/2004
12Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2011 - 11/2002
9AutoantigensIBA
01/2020 - 08/2007
8Myelin-Oligodendrocyte GlycoproteinIBA
07/2024 - 05/2011
7AutoantibodiesIBA
04/2024 - 11/2010
7Immunoglobulin G (IgG)IBA
01/2023 - 11/2010
7CytokinesIBA
01/2020 - 11/2002
7Natalizumab (Tysabri)FDA Link
01/2019 - 07/2006
5Monoclonal AntibodiesIBA
11/2023 - 08/2010
5Proteins (Proteins, Gene)FDA Link
10/2021 - 12/2004
5Aquaporins (Water Channels)IBA
01/2018 - 11/2010
5Peptides (Polypeptides)IBA
04/2016 - 12/2004
4Rituximab (Mabthera)FDA Link
01/2024 - 08/2009
4EpitopesIBA
10/2021 - 05/2017
4Immunoglobulins (Immunoglobulin)IBA
01/2020 - 07/2012
4InterferonsIBA
01/2020 - 11/2002
4laquinimodIBA
10/2016 - 01/2012
4Interferon-betaIBA
01/2005 - 09/2002
3SteroidsIBA
07/2024 - 01/2023
3ocrelizumabIBA
11/2023 - 01/2016
3Messenger RNA (mRNA)IBA
11/2023 - 11/2021
3COVID-19 VaccinesIBA
02/2023 - 09/2021
3Biomarkers (Surrogate Marker)IBA
01/2023 - 07/2013
3Retinaldehyde (Retinal)IBA
01/2023 - 01/2017
3Oligoclonal BandsIBA
01/2023 - 12/2016
3Fibrinogen (Factor I)FDA Link
01/2023 - 09/2015
3AntigensIBA
01/2020 - 08/2007
3Atorvastatin (Lipitor)FDA Link
02/2014 - 11/2002
3Immunosuppressive Agents (Immunosuppressants)IBA
02/2011 - 06/2004
3Mitoxantrone (Novantrone)FDA LinkGeneric
07/2006 - 06/2004
2BNT162 VaccineIBA
11/2023 - 04/2022
2FibrinIBA
10/2021 - 11/2018
2Alemtuzumab (Campath)FDA Link
11/2020 - 10/2020
2Therapeutic UsesIBA
01/2020 - 08/2007
2ChemokinesIBA
01/2020 - 09/2015
2Cholecalciferol (Vitamin D3)FDA Link
12/2019 - 01/2019
2Immunoglobulin A (IgA)IBA
04/2019 - 01/2019
2Interleukin-10 (Interleukin 10)IBA
04/2019 - 01/2019
2Amino AcidsFDA Link
01/2019 - 08/2014
2T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2016 - 08/2014
2EnzymesIBA
12/2016 - 02/2006
2Dimethyl FumarateIBA
04/2016 - 06/2015
2Integrin alpha4beta1 (VLA-4)IBA
04/2016 - 05/2015
2peptide PIBA
08/2014 - 05/2013
2Immunomodulating AgentsIBA
02/2011 - 06/2004
2Neutralizing AntibodiesIBA
11/2007 - 12/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2007 - 11/2002
2Interleukin-12 (IL 12)IBA
08/2007 - 11/2002
2Simvastatin (Zocor)FDA LinkGeneric
01/2007 - 01/2005
2Coenzyme A (CoA)IBA
09/2006 - 12/2005
2Oxidoreductases (Dehydrogenase)IBA
09/2006 - 12/2005
2CholesterolIBA
09/2006 - 05/2006
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2024
1mRNA VaccinesIBA
11/2023
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2023
1satralizumabIBA
01/2023
1Hormones (Hormone)IBA
05/2022
1VaccinesIBA
11/2021
1Indicators and Reagents (Reagents)IBA
11/2021

Therapy/Procedure

36Therapeutics
05/2022 - 09/2002
5Immunotherapy
01/2023 - 11/2018
2Drug Therapy (Chemotherapy)
11/2010 - 09/2002
1Plasmapheresis
01/2024
1Aftercare (After-Treatment)
01/2024